June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Jason Carey: ASCO 2025 Spotlight – Early Detection is Changing the Game
Jun 7, 2025, 11:58

Jason Carey: ASCO 2025 Spotlight – Early Detection is Changing the Game

Jason Carey, Senior Medical Science Liaison at GRAIL, shared a post on LinkedIn:

“ASCO 2025 Spotlight: Early Detection is Changing the Game
This year’s ASCO meeting made one thing crystal clear: multi-cancer early detection (MCED) is no longer a futuristic concept – it’s here, and it’s impacting lives.
Here are some of the most impactful updates on cancer screening and early detection:

1. GRAIL’s CCGA Study – 5-Year Follow-Up Data

– GRAIL presented powerful follow-up data from its Circulating Cell-free Genome Atlas (CCGA) study.
– The test continues to show preferential detection of high-grade, clinically significant cancers—including aggressive prostate cancers—while reducing the risk of overdiagnosing indolent disease.
Bottom line: Earlier detection => better long-term survival.

2. Dana-Farber’s Real-World MCED Experience

– Dana-Farber shared real-world data on MCED test implementation.
– Their analysis showed clinical utility and outcomes of integrating MCED into routine practice.
– Real data. Real patients. Real potential.

3. MCED Screening Interval Modeling

 Should we screen annually or every other year?
Modeling shows:
– Annual MCED screening could reduce late-stage diagnoses by 43%
– And cut cancer-related deaths by 16% over 5 years
– A powerful complement to existing guideline-based screening.
Takeaway:
Early detection isn’t just a buzzword. The data proves we can intervene earlier, save more lives, and change the cancer care continuum.”

Read OncoDaily’s Special Articles from ASCO25: 

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

Highlights from ASCO 2025 Day 4

Clifford Hudis ASCO 2025